ReviewPharmaceutics2022

Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery.

Harpinder K Brar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.